RECTAL TUMOROIDS AS A NEW TRANSLATIONAL MEDICINE MODEL OF RECTAL CANCER

During the summer of 2019, I had the privilege of being accepted into the Human Oncology & Pathogenesis Program at Memorial Sloan Kettering Cancer Center. My research was primarily based on the utilization of tumoroid technology and how it is used in a translational setting. 

Colorectal cancer is the 2nd leading cause of cancer death among men and women. However, rectal cancer patients do not have many targeted treatment therapies and often have to resort to less effective, traditional methods. However, the utilization of organoid technology can revolutionize rectal cancer treatment. In this project, I explored the viability of organoids within the lab that were fostered and targeted with various drugs.